Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature

Immunotherapy with PD-1 inhibitors monotherapy or combined with chemotherapy comprises the first-line palliative treatment for patients with recurrent or metastatic head and neck squamous cell cancers (R/M HNSCC). The established survival advantage among responders is overshadowed by the high percen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloomer, Chance H., Gavrila, Elena, Burcher, Kimberly M., Kalada, John M., Chang, Mark J., Gebeyehu, Rediet R., Asare, Elsabeth, Khoury, Lara M., Kinney, Rebecca, Frizzell, Bart, Sullivan, Christopher A., Bunch, Paul M., Porosnicu, Mercedes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475238/
https://www.ncbi.nlm.nih.gov/pubmed/37667781
http://dx.doi.org/10.1177/17588359231193722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475238/
https://www.ncbi.nlm.nih.gov/pubmed/37667781
http://dx.doi.org/10.1177/17588359231193722

Ejemplares similares